Inhaled corticosteroids with combination inhaled long‐acting beta(2)‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease

BACKGROUND: Management of chronic obstructive pulmonary disease (COPD) commonly involves long‐acting bronchodilators including beta‐agonists (LABA) and muscarinic antagonists (LAMA). In individuals with persistent symptoms or frequent exacerbations, inhaled corticosteroids (ICS) are also used. LABA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Tan, Daniel J, White, Clinton J, Walters, Julia AE, Walters, E Haydn
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2016
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464947/
https://ncbi.nlm.nih.gov/pubmed/27830584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011600.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller